|
Market Closed -
Nasdaq
01:30:00 29/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 22.50 USD | -18.30% |
|
-10.22% | -25.84% |
| 28/10 | Rapport Therapeutics Prices Stock, Convertible Notes Offerings; Private Placement; Shares Fall | MT |
| 28/10 | Top Premarket Decliners | MT |
| Market Cap | 107.95Cr 97Cr 90Cr 81Cr 151.51Cr 10TCr 153.34Cr 1.07TCr 426.44Cr 5.38TCr 405.1Cr 396.55Cr 17TCr | P/E 2026 * |
-5.61x | P/E 2027 * | -4.59x |
|---|---|---|---|---|---|
| Enterprise Value | 75Cr 67Cr 62Cr 56Cr 105.12Cr 7.13TCr 106.39Cr 742.83Cr 295.87Cr 3.73TCr 281.07Cr 275.13Cr 12TCr | EV / Sales 2026 * |
37.3x | EV / Sales 2027 * | - |
| Free-Float |
96.09% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| RAPP | Delayed | |
CBOE
| RAPP | Real-time |
Last Transcript: Rapport Therapeutics, Inc.
| 1 day | -18.30% | ||
| 1 week | -10.22% | ||
| Current month | -33.04% | ||
| 1 month | -32.72% | ||
| 3 months | -46.38% | ||
| 6 months | -33.31% | ||
| Current year | -25.84% |
| 1 week | 22.06 |  | 28.31 |
| 1 month | 22.06 | | 34.48 |
| Current year | 22.06 | | 52.93 |
| 1 year | 22.06 | | 52.93 |
| 3 years | 6.43 | | 52.93 |
| 5 years | 6.43 | | 52.93 |
| 10 years | 6.43 | | 52.93 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Bredt
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/01/2023 |
Abraham Ceesay
CEO | Chief Executive Officer | 48 | 01/02/2023 |
Troy Ignelzi
DFI | Director of Finance/CFO | 58 | 01/11/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
James Healy
BRD | Director/Board Member | 61 | 23/08/2023 |
Abraham Ceesay
BRD | Director/Board Member | 48 | 01/03/2023 |
Reid Huber
BRD | Director/Board Member | 54 | 01/02/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 07/10/26 | Sell | Chief Executive Officer | -1,147 | 0.0024% | ||
| 30/09/26 | Sell | Chief Operating Officer | -10,000 | 0.0208% | ||
| 23/09/26 | Sell | Chief Executive Officer | -2,210 | 0.0046% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -18.30% | -10.22% | -22.31% | - | 107.95Cr | |
| +0.65% | -3.36% | +36.98% | +60.50% | 6.41TCr | |
| +1.13% | +2.83% | +12.42% | +84.18% | 5.55TCr | |
| +1.54% | +1.81% | +13.08% | +105.33% | 5.3TCr | |
| +2.76% | +0.87% | +27.92% | +55.07% | 4.6TCr | |
| +2.00% | -3.39% | +17.83% | +119.04% | 4.25TCr | |
| +1.34% | -2.86% | +224.43% | +914.08% | 4.04TCr | |
| +0.64% | -3.95% | +11.15% | +45.57% | 3.23TCr | |
| -2.34% | +41.86% | +102.53% | +89.10% | 3.45TCr | |
| -2.72% | -0.44% | +23.18% | -10.77% | 2.42TCr | |
| Average | -1.33% | +2.65% | +44.72% | +162.46% | 3.94TCr | |
| Weighted average by Cap. | +0.78% | +3.45% | +49.05% | +160.44% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.01Cr 1.8Cr 1.66Cr 1.51Cr 2.82Cr 191.08Cr 2.85Cr 20Cr 7.93Cr 100Cr 7.53Cr 7.37Cr 317.42Cr | - |
| Net income | -19Cr -17Cr -16Cr -14Cr -27Cr -1.84TCr -27Cr -191.34Cr -76Cr -961.5Cr -72Cr -71Cr -3.05TCr | -25Cr -23Cr -21Cr -19Cr -36Cr -2.42TCr -36Cr -251.59Cr -100.21Cr -1.26TCr -95Cr -93Cr -4.01TCr |
| Net Debt | -33Cr -30Cr -27Cr -25Cr -46Cr -3.15TCr -47Cr -327.8Cr -130.57Cr -1.65TCr -124.03Cr -121.41Cr -5.23TCr | -31Cr -28Cr -26Cr -23Cr -43Cr -2.95TCr -44Cr -306.81Cr -122.2Cr -1.54TCr -116.09Cr -113.64Cr -4.89TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/26/28 | $22.50 | -18.30% | 59,60,886 |
| 27/26/27 | $27.54 | +8.72% | 7,03,926 |
| 26/26/26 | $25.33 | -2.31% | 10,41,210 |
| 23/26/23 | $25.93 | -2.26% | 11,85,460 |
| 22/26/22 | $26.53 | +5.87% | 14,59,476 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RAPP Stock
Select your edition
All financial news and data tailored to specific country editions
